Gene Expression Profiling and Interactive Analyses (GEPIA2) (Tang et al., 2017) (http://gepia2.cancer-pku.cn/#index) were used to profile the tissue-wise expression of RCN1 in GBM. This evidence concerns the gene RCN1 and glioblastoma.